Adagene stock soars after FDA grants Fast Track status for cancer therapy

Adagene stock soars after FDA grants Fast Track status for cancer therapy
Source link

Adagene stock soars after FDA grants Fast Track status for cancer therapy
Source link
A small green candle was formed on the daily chart with a long lower shadow. Technically, this market action could mean weakness in the market with range-bound action, which is also signaling the absence of sharp downside momentum from the swing highs. Previous bearish patterns like lower tops and bottoms are in the process of…
Oramed Pharmaceuticals (NASDAQ:ORMP – Get Free Report) announced its quarterly earnings results on Thursday. The biotechnology company reported ($0.05) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.04) by ($0.01). Source link
Nasdaq 100 Future: Market Trends & Nvidia’s Impact Home Stocks Nasdaq 100 Future: Market Trends & Nvidia’s Impact Source link
The GIFT Nifty futures, which is an early indicator of the Nifty50 index, was trading 0.04% lower by 9.50 points at 22,909 indicating that the domestic benchmark indices are likely to make a muted start on Friday. On Thursday, 6 June, Domestic benchmark indices S&P BSE Sensex soared 692 points, or 0.93%, to end at…
Wall St futures steady ahead of Good Friday break; focus on jobs data Source link
On 21 August, Intuit (INTU) increased its dividend by 15.38%, from $1.04 to $1.20 per share. The dividend is payable on 17 October to shareholders of record on 9 October. INTU’s forward yield is 0.72% at $666.80 per share. I own 36 INTU shares at an average cost of $599.56 per share. INTU’s contribution to DivGro‘s projected annual dividend income will increase…